A computational solution for bolstering reliability of epigenetic clocks: Implications for clinical trials and longitudinal tracking.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36277076.
- Also identified by DOI 10.1038/s43587-022-00248-2 and PMC identifier 9586209.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Epigenetic clocks are widely used aging biomarkers calculated from DNA methylation data, but this data can be surprisingly unreliable. Here we show technical noise produces deviations up to 9 years between replicates for six prominent epigenetic clocks, limiting their utility. We present a computational solution to bolster reliability, calculating principal components from CpG-level data as input for biological age prediction. Our retrained principal-component versions of six clocks show agreement between most replicates within 1.5 years, improved detection of clock associations and intervention effects, and reliable longitudinal trajectories <i>in vivo</i> and <i>in vitro</i>. This method entails only one additional step compared to traditional clocks, requires no replicates or prior knowledge of CpG reliabilities for training, and can be applied to any existing or future epigenetic biomarker. The high reliability of principal component-based clocks is critical for applications to personalized medicine, longitudinal tracking, <i>in vitro</i> studies, and clinical trials of aging interventions.
Medical subject headings
- Epigenesis, Genetic
- DNA Methylation